A Fenofibrate Diet Prevents Paclitaxel-Induced Peripheral Neuropathy in Mice
Background: Paclitaxel-induced peripheral neuropathy (PIPN) is a major adverse effect of this chemotherapeutic agent that is used in the treatment of a number of solid malignancies. PIPN leads notably to burning pain, cold and mechanical allodynia. PIPN is thought to be a consequence of alterations...
Main Authors: | Martial Caillaud, Nipa H. Patel, Wisam Toma, Alyssa White, Danielle Thompson, Jared Mann, Tammy H. Tran, Jane L. Roberts, Justin L. Poklis, John W. Bigbee, Xianjun Fang, David A. Gewirtz, M. Imad Damaj |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/1/69 |
Similar Items
-
Anti-inflammatory role of fenofibrate in treating diseases
by: Lv Jin, et al.
Published: (2023-05-01) -
Effect of fenofibrate and selective PPARα modulator (SPPARMα), pemafibrate on KATP channel activity and insulin secretion
by: Shigeki Kitamura, et al.
Published: (2023-09-01) -
Formulated Curcumin Prevents Paclitaxel-Induced Peripheral Neuropathy through Reduction in Neuroinflammation by Modulation of α7 Nicotinic Acetylcholine Receptors
by: Martial Caillaud, et al.
Published: (2022-06-01) -
Berberine Alleviates Paclitaxel-Induced Neuropathy
by: Ramin Rezaee, et al.
Published: (2019-06-01) -
Fenofibrate inhibits TGF‐β‐induced myofibroblast differentiation and activation in human lung fibroblasts in vitro
by: Ryota Kikuchi, et al.
Published: (2021-08-01)